Cardiovascular disease outcomes in relation to 25-hydroxyvitamin D and its seasonal variation: Results from the BiomarCaRE consortium
Viktor Oskarsson(Umeå University), Stefan Söderberg(Umeå University), Simona Costanzo(Istituto Neurologico Mediterraneo), Chiara Donfrancesco, Giancarlo Cesana(University of Milano-Bicocca), Licia Iacoviello(Istituto Neurologico Mediterraneo), Mark Woodward(UNSW Sydney), Kari Kuulasmaa(Finnish Institute for Health and Welfare), Tanja Zeller(Universität Hamburg), Barbara Thorand(Helmholtz Zentrum München), Hugh Tunstall‐Pedoe(University of Dundee), Susana Sans(Health Research Institute of the Balearic Islands), Veikko Salomaa(Finnish Institute for Health and Welfare), Pekka Jousilahti(Finnish Institute for Health and Welfare), Maurizio Ferrario(University of Insubria), Luigi Palmieri(Istituto Superiore di Sanità), Stefan Blankenberg(Universität Hamburg), Annette Peters(Center for Environmental Health)
Cited by 4
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
|The Lancet|2010|4.2k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k